Targeting the CD40/CD40 ligand (CD154) interaction by CD40 siRNA given to bone-marrow-derived DCs attenuated allergic rhinitis and induced the conversion of CD4+ T cells into regulatory T cells [34]. Here, CD40 is linked to allergic rhinitis.